TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5).
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
University of California Los Angeles, Los Angeles, California, United States
University of California San Francisco, San Francisco, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.